Sq Advisors Stake in Allison Transmission Hldgs I (ALSN) Has Cut by $9.45 Million; Gmt Capital Holding in Biogen (BIIB) Has Lowered as Stock Declined

Biogen Inc. (NASDAQ:BIIB) Logo

Gmt Capital Corp decreased its stake in Biogen Inc (BIIB) by 4.68% based on its latest 2018Q3 regulatory filing with the SEC. Gmt Capital Corp sold 16,850 shares as the company’s stock declined 6.12% with the market. The hedge fund held 343,550 shares of the biological products (no diagnostic substances) company at the end of 2018Q3, valued at $121.38M, down from 360,400 at the end of the previous reported quarter. Gmt Capital Corp who had been investing in Biogen Inc for a number of months, seems to be less bullish one the $66.19B market cap company. The stock increased 1.25% or $4.07 during the last trading session, reaching $328.51. About 699,723 shares traded. Biogen Inc. (NASDAQ:BIIB) has declined 0.04% since January 9, 2018 and is downtrending. It has underperformed by 0.04% the S&P500. Some Historical BIIB News: 05/04/2018 – Biogen and Samsung Bioepis Agree to Settlement with AbbVie Allowing Commercialization of IMRALDI™ (Adalimumab Biosimilar) in; 24/04/2018 – BIOGEN INC – QTRLY TYSABRI REVENUE OF $$462 MLN VS. $545 MLN REPORTED LAST YEAR; 20/04/2018 – BIOGEN INC – IN COLLABORATION, IONIS WILL BE RESPONSIBLE FOR IDENTIFICATION OF ANTISENSE DRUG CANDIDATES BASED ON SELECTED TARGETS; 24/04/2018 – Biogen quarterly profit jumps on higher Spinraza sales; 13/04/2018 – Biogen’s Tecfidera Weekly Retail Sales Rose 0.5%: Symphony; 01/05/2018 – Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab; 25/04/2018 – BIOGEN INC BIIB.O : BAIRD RAISES TO OUTPERFORM; 12/03/2018 – Biogen to Acquire from Pfizer First-in-Class Phase 2b Ready Asset for Cognitive Impairment Associated with Schizophrenia; 12/03/2018 – Biogen Expects Deal to Close in 2Q; 20/04/2018 – Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases

Sq Advisors Llc decreased its stake in Allison Transmission Hldgs I (ALSN) by 2.05% based on its latest 2018Q3 regulatory filing with the SEC. Sq Advisors Llc sold 181,746 shares as the company’s stock declined 16.65% with the market. The hedge fund held 8.68M shares of the capital goods company at the end of 2018Q3, valued at $451.20M, down from 8.86M at the end of the previous reported quarter. Sq Advisors Llc who had been investing in Allison Transmission Hldgs I for a number of months, seems to be less bullish one the $5.98B market cap company. The stock increased 0.76% or $0.35 during the last trading session, reaching $46.15. About 333,745 shares traded. Allison Transmission Holdings, Inc. (NYSE:ALSN) has risen 3.67% since January 9, 2018 and is uptrending. It has outperformed by 3.67% the S&P500. Some Historical ALSN News: 16/03/2018 – DEEP ECO: ALSN May Benefit, Industry Posts 10th Consecutive Gain; 08/03/2018 – Navistar to offer an Allison transmission standard with new lnternational® MV Series truck; 26/04/2018 – IC Bus chooses Allison Transmission for its alternative fuel-powered CE Series school buses; 17/04/2018 – DEEP ECO: ALSN May Benefit, Industry Posts 11th Consecutive Gain; 05/03/2018 – INFOSYS WINS CONTRACT FROM ALLISON TRANSMISSION: STATEMENT; 19/04/2018 – DJ Allison Transmission Holdings Inc, Inst Holders, 1Q 2018 (ALSN); 05/03/2018 – lnfosys Selected by Allison Transmission to Provide Next-Generation Infrastructure Management Services; 06/03/2018 – ALLISON TRANSMISSION – UNIT IS SEEKING TO AMEND CREDIT AGREEMENT TO REDUCE INTEREST RATE MARGIN ON TERM B-3 LOAN DUE 2022; 11/05/2018 – Allison Transmission Names Fred Bohley CFO; 05/03/2018 INFOSYS LTD: INFOSYS SELECTED BY ALLISON TRANSMISSION TO PROVID

Among 23 analysts covering Allison Transmission Holdings (NYSE:ALSN), 10 have Buy rating, 5 Sell and 8 Hold. Therefore 43% are positive. Allison Transmission Holdings had 85 analyst reports since July 30, 2015 according to SRatingsIntel. The company was maintained on Tuesday, October 31 by Stifel Nicolaus. As per Friday, November 17, the company rating was maintained by Piper Jaffray. The company was maintained on Friday, April 28 by Piper Jaffray. On Friday, December 9 the stock rating was upgraded by JP Morgan to “Overweight”. The stock of Allison Transmission Holdings, Inc. (NYSE:ALSN) earned “Outperform” rating by RBC Capital Markets on Friday, April 28. Robert W. Baird downgraded Allison Transmission Holdings, Inc. (NYSE:ALSN) rating on Monday, January 4. Robert W. Baird has “Neutral” rating and $28 target. The stock of Allison Transmission Holdings, Inc. (NYSE:ALSN) earned “Mkt Outperform” rating by Avondale on Wednesday, December 2. The company was downgraded on Friday, December 9 by Piper Jaffray. The stock of Allison Transmission Holdings, Inc. (NYSE:ALSN) earned “Neutral” rating by Buckingham Research on Thursday, October 11. Citigroup upgraded the stock to “Buy” rating in Tuesday, January 24 report.

Since August 20, 2018, it had 0 insider purchases, and 6 sales for $28.71 million activity. Another trade for 4,940 shares valued at $242,082 was made by Scroggins Eric C. on Tuesday, August 21. Graziosi David S. sold $242,622 worth of stock.

Analysts await Allison Transmission Holdings, Inc. (NYSE:ALSN) to report earnings on February, 13. They expect $0.95 earnings per share, up 17.28% or $0.14 from last year’s $0.81 per share. ALSN’s profit will be $123.16 million for 12.14 P/E if the $0.95 EPS becomes a reality. After $1.27 actual earnings per share reported by Allison Transmission Holdings, Inc. for the previous quarter, Wall Street now forecasts -25.20% negative EPS growth.

Investors sentiment decreased to 1.05 in Q3 2018. Its down 0.16, from 1.21 in 2018Q2. It turned negative, as 21 investors sold ALSN shares while 111 reduced holdings. 53 funds opened positions while 85 raised stakes. 122.71 million shares or 5.24% less from 129.50 million shares in 2018Q2 were reported. Colony Limited Liability Com owns 87,476 shares. Alpha Windward Limited Com holds 0.37% or 11,819 shares. State Of Alaska Department Of Revenue accumulated 0.01% or 14,044 shares. Moreover, Balyasny Asset Mgmt Ltd Com has 0.01% invested in Allison Transmission Holdings, Inc. (NYSE:ALSN) for 60,897 shares. Natixis Advsr Ltd Partnership holds 108,624 shares or 0.05% of its portfolio. Stifel invested in 0.02% or 162,719 shares. Prudential Public Limited accumulated 4,200 shares. Ameriprise Financial holds 0.01% or 398,567 shares. Prelude Capital Ltd Company accumulated 5,950 shares. 1,302 are owned by Bessemer Group Inc. Moreover, Gotham Asset Mgmt Limited Liability Co has 0.32% invested in Allison Transmission Holdings, Inc. (NYSE:ALSN). Virtu Financial holds 6,079 shares or 0% of its portfolio. Public Sector Pension Board reported 75,104 shares. Jpmorgan Chase And stated it has 2.27 million shares. Sterling Limited Liability Co reported 86,236 shares.

More notable recent Allison Transmission Holdings, Inc. (NYSE:ALSN) news were published by: Fool.com which released: “Why Allison Transmission Stock Popped 10% – Motley Fool” on July 31, 2018, also Benzinga.com with their article: “Allison Transmission (NYSE:ALSN)’s Highest-Margin Segment Is ‘Likely To Slow,’ BofA Says In Downgrade – Benzinga” published on February 08, 2018, Seekingalpha.com published: “Class 8 truck orders fall in November – Seeking Alpha” on December 05, 2018. More interesting news about Allison Transmission Holdings, Inc. (NYSE:ALSN) were released by: Seekingalpha.com and their article: “Allison Transmission Is A Buy – Seeking Alpha” published on July 16, 2018 as well as Seekingalpha.com‘s news article titled: “Digging deep into trucking data – Seeking Alpha” with publication date: October 22, 2018.

Analysts await Biogen Inc. (NASDAQ:BIIB) to report earnings on January, 29 before the open. They expect $6.72 earnings per share, up 27.76% or $1.46 from last year’s $5.26 per share. BIIB’s profit will be $1.35 billion for 12.22 P/E if the $6.72 EPS becomes a reality. After $7.40 actual earnings per share reported by Biogen Inc. for the previous quarter, Wall Street now forecasts -9.19% negative EPS growth.

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Nasdaq.com which released: “Surprising Analyst 12-Month Target For QUS – Nasdaq” on December 18, 2018, also Seekingalpha.com with their article: “Biogen commences late-stage study of extended interval dosing for MS med Tysabri – Seeking Alpha” published on January 03, 2019, Nasdaq.com published: “Alkermes and Biogen Announce Submission of a New Drug Application to US Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis – Nasdaq” on December 17, 2018. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Nasdaq.com and their article: “Biogen Inks Two Deals to Make Drugs for Neurological Diseases – Nasdaq” published on January 07, 2019 as well as Streetinsider.com‘s news article titled: “Biogen (BIIB) Applauds Quebec Decision to Cover SPINRAZA for broad population of SMA Patients – StreetInsider.com” with publication date: December 20, 2018.

Gmt Capital Corp, which manages about $9.19B and $3.85B US Long portfolio, upped its stake in Norwegian Cruise Line Hldg L (NASDAQ:NCLH) by 155,440 shares to 518,340 shares, valued at $29.77M in 2018Q3, according to the filing. It also increased its holding in Baidu Inc (NASDAQ:BIDU) by 27,520 shares in the quarter, for a total of 236,150 shares, and has risen its stake in Cigna Corporation (NYSE:CI).

Since September 26, 2018, it had 0 buys, and 1 sale for $350,000 activity.

Investors sentiment decreased to 1.01 in Q3 2018. Its down 0.01, from 1.02 in 2018Q2. It dropped, as 45 investors sold BIIB shares while 334 reduced holdings. 138 funds opened positions while 243 raised stakes. 167.21 million shares or 1.69% less from 170.10 million shares in 2018Q2 were reported. Garde Capital has invested 0.08% in Biogen Inc. (NASDAQ:BIIB). Ironwood Inv Counsel Ltd Liability Company accumulated 0.36% or 2,626 shares. Cwm Ltd stated it has 130 shares or 0% of all its holdings. Mairs Power invested 0% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Aqr Capital Management Lc accumulated 2.84 million shares. Citadel Advsrs Ltd Limited Liability Company holds 0.01% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 55,500 shares. Nuwave Management Limited Liability invested in 0.42% or 782 shares. Los Angeles Cap Mgmt Equity Research reported 51,423 shares. Clough Capital LP has 9,197 shares. Janney Capital Mgmt Ltd has invested 0.15% in Biogen Inc. (NASDAQ:BIIB). North Star Asset Mgmt stated it has 0.05% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Invesco reported 3.61M shares. Barrett Asset Mngmt Ltd Llc owns 104 shares. Da Davidson holds 0.15% or 23,776 shares in its portfolio. Bridges Mngmt has 25,597 shares.

Among 35 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 27 have Buy rating, 0 Sell and 8 Hold. Therefore 77% are positive. Biogen Idec Inc. had 147 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Neutral” rating by Robert W. Baird on Tuesday, July 10. Cantor Fitzgerald maintained the stock with “Hold” rating in Wednesday, April 25 report. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, July 26. On Monday, July 23 the stock rating was maintained by Canaccord Genuity with “Buy”. The firm earned “Buy” rating on Tuesday, November 8 by Mizuho. Guggenheim initiated the shares of BIIB in report on Monday, October 23 with “Buy” rating. The firm has “Buy” rating given on Tuesday, October 24 by Goldman Sachs. The firm earned “Equal-Weight” rating on Thursday, April 5 by Barclays Capital. Mizuho maintained it with “Buy” rating and $433.0 target in Sunday, February 4 report. RBC Capital Markets maintained Biogen Inc. (NASDAQ:BIIB) on Friday, March 2 with “Hold” rating.

Allison Transmission Holdings, Inc. (NYSE:ALSN) Ratings Chart